Quantcast
Last updated on April 18, 2014 at 21:21 EDT

SynCardia Named One of “America’s Most Promising Companies” by Forbes

December 8, 2011

List Features 100 Privately-Held Companies with Compelling Business Models, Strong, Management Teams, Investment Capital and Notable Customers

Tucson, Ariz. (PRWEB) December 08, 2011

SynCardia Systems, Inc., the privately-held manufacturer of the worldâs only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, has been selected by Forbes as one of âœAmericaâs Most Promising Companies.â The list features 100 privately held up-and-comers with compelling business models, strong management teams, notable customers, strategic partners and precious investment capital. Ranked No. 77, SynCardia was the only Arizona company to make the cut.

âœIn 2010, SynCardia doubled sales over 2009, and in 2011, we are on track to double sales again, representing a four-fold increase since 2009. We are profitable for the first time in the companyâs 10-year history,â said Michael Garippa, CEO/President. âœSynCardia is lean by design and many of our employees are cross-trained in multiple departments. Every Friday, we continue our six-year tradition of the entire company having lunch together and sharing project updates to ensure everyone is on the same page.â

SynCardia designed, developed, and launched the Freedom® portable driver, the world’s first wearable power supply for the SynCardia temporary Total Artificial Heart. Weighing 13.5 pounds, the Freedom driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S. To date, 34 patients have been enrolled in the study. Of these patients, 23 have been discharged from the hospital using the Freedom driver. The study requires that 30 patients be discharged.

Worldwide, more than 65 patients have been supported by the Freedom portable driver. From Russia to Richmond, from Australia to Arizona, Total Artificial Heart patients have been discharged from the hospital without human hearts to wait for a matching donor heart at home and in their communities. There are currently SynCardia Certified Centers in 12 countries on 3 continents â“ North America, Europe and Australia.

Prior to the development of the Freedom driver, stable Total Artificial Heart patients in the U.S. were confined to the hospital for months, sometimes years while they waited for a matching donor heart because the only FDA-approved driver is hospital-based âœBig Blueâ which weighs 418 pounds.

SynCardia has been honored with multiple awards in 2011, including being ranked #20 in Fast Companyâs annual list of the âœWorldâs 50 Most Innovative Companies,â named âœArizona Bioscience Company of the Yearâ and selected as one of six finalists for the World Technology Award in Health and Medicine by the World Technology Network in association with TIME, Fortune, CNN, Science/AAAS and Technology Review.

To view the complete the list of Americaâs Most Promising Companies, please visit http://www.forbes.com/ampc.

CAUTION â“ The Freedom® portable driver is an investigational device, limited by United States law to investigational use.

About the SynCardia temporary Total Artificial Heart

SynCardia Systems, Inc. manufactures the worldâs first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart, the Total is currently approved as a bridge to transplant for people dying from end-stage heart failure affecting both sides of the heart (biventricular failure). More than 950 implants account for more than 230 patient years of life.

Similar to a heart transplant, SynCardiaâs Total Artificial Heart replaces both failing heart ventricles and the four heart valves. It is the only device that eliminates the symptoms and source of end-stage biventricular heart failure and pumps up to 9.5 liters per minute through both ventricles. This high volume of safe blood flow helps speed the recovery of vital organs, helping make the patient a better transplant candidate.

Fast Company ranked SynCardia#20 among the Worldâs 50 Most Innovative Companies âœfor giving mobility to artificial heart recipients.â

SynCardia on Facebook

Twitter: @SynCardia

SynCardia on LinkedIn

###

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2011/12/prweb9023785.htm


Source: prweb